.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Hydrochlorothiazide, and what substitute generic drugs are available?

Hydrochlorothiazide is a drug marketed by Leading Pharma Llc, Watson Labs, Roxane, Ivax Sub Teva Pharms, Prinston Inc, Actavis Elizabeth, Impax Labs, Ipca Labs Ltd, Unichem, Jubilant Cadista, Whiteworth Town Plsn, Sun Pharm Inds Inc, Vangard, Mylan, Sandoz, Sciegen Pharms Inc, Aurolife Pharma Llc, Solvay, Teva, Lannett, Superpharm, Usl Pharma, Heather, Mylan Pharms Inc, Ascot, Alembic Pharms Ltd, Elkins Sinn, Alra, Accord Hlthcare, Dava Pharms Inc, Morton Grove, Lannett Holdings Inc, Aurobindo Pharma, Tg United Labs, Inwood Labs, Barr, Abc Holding, Sun Pharm Inds, Apotex, Hikma Intl Pharms, Heritage Pharms Inc, Warner Chilcott, Mast Mm, Pvt Form, West Ward, and Pharmeral. and is included in one hundred and nine NDAs.

The generic ingredient in HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.

Summary for Tradename: HYDROCHLOROTHIAZIDE

Patents:0
Applicants:46
NDAs:109
Suppliers / Packagers: see list74
Bulk Api Vendors: see list77
Clinical Trials: see list82
Patent Applications: see list7,067
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYDROCHLOROTHIAZIDE at DailyMed

Pharmacology for Tradename: HYDROCHLOROTHIAZIDE

Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma
HYDROCHLOROTHIAZIDE
hydrochlorothiazide
CAPSULE;ORAL078164-001Sep 18, 2007RXNoNo► Subscribe► Subscribe
Warner Chilcott
HYDROCHLOROTHIAZIDE
hydrochlorothiazide
TABLET;ORAL087587-001May 3, 1982DISCNNoNo► Subscribe► Subscribe
Superpharm
HYDROCHLOROTHIAZIDE
hydrochlorothiazide
TABLET;ORAL088829-001Dec 28, 1984DISCNNoNo► Subscribe► Subscribe
Solvay
HYDROCHLOROTHIAZIDE
hydrochlorothiazide
TABLET;ORAL085323-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Inwood Labs
HYDROCHLOROTHIAZIDE
hydrochlorothiazide
TABLET;ORAL084776-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc